These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32545222)

  • 1. Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy.
    Rossino MG; Lulli M; Amato R; Cammalleri M; Monte MD; Casini G
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRF2 plays a protective role in diabetic retinopathy in mice.
    Xu Z; Wei Y; Gong J; Cho H; Park JK; Sung ER; Huang H; Wu L; Eberhart C; Handa JT; Du Y; Kern TS; Thimmulappa R; Barber AJ; Biswal S; Duh EJ
    Diabetologia; 2014 Jan; 57(1):204-13. PubMed ID: 24186494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
    Amato R; Biagioni M; Cammalleri M; Dal Monte M; Casini G
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3066-76. PubMed ID: 27286364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy.
    Wei J; Jiang H; Gao H; Wang G
    Cell Physiol Biochem; 2016; 40(6):1570-1577. PubMed ID: 27997905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
    Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
    Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying somatostatin receptor 2 down-regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants.
    Mei S; Cammalleri M; Azara D; Casini G; Bagnoli P; Dal Monte M
    J Pathol; 2012 Feb; 226(3):519-33. PubMed ID: 21960021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
    Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
    Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth and aggressive behavior of human osteosarcoma is regulated by a CaMKII-controlled autocrine VEGF signaling mechanism.
    Daft PG; Yang Y; Napierala D; Zayzafoon M
    PLoS One; 2015; 10(4):e0121568. PubMed ID: 25860662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased K5 receptor expression in the retina, a potential pathogenic mechanism for diabetic retinopathy.
    Ma J; Li C; Shao C; Gao G; Yang X
    Mol Vis; 2012; 18():330-6. PubMed ID: 22355244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes.
    Mima A; Qi W; Hiraoka-Yamomoto J; Park K; Matsumoto M; Kitada M; Li Q; Mizutani K; Yu E; Shimada T; Lee J; Shoelson SE; Jobin C; Rask-Madsen C; King GL
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8424-32. PubMed ID: 23197686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells.
    Kusunose N; Akamine T; Kobayashi Y; Yoshida S; Kimoto K; Yasukochi S; Matsunaga N; Koyanagi S; Ohdo S; Kubota T
    Jpn J Ophthalmol; 2018 Nov; 62(6):677-685. PubMed ID: 30250985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
    Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction.
    Bento CF; Fernandes R; Matafome P; Sena C; Seiça R; Pereira P
    Exp Physiol; 2010 Sep; 95(9):955-70. PubMed ID: 20562294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
    Kolibabka M; Dietrich N; Klein T; Hammes HP
    Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products increase retinal vascular endothelial growth factor expression.
    Lu M; Kuroki M; Amano S; Tolentino M; Keough K; Kim I; Bucala R; Adamis AP
    J Clin Invest; 1998 Mar; 101(6):1219-24. PubMed ID: 9502762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes.
    Duarte DA; Papadimitriou A; Gilbert RE; Thai K; Zhang Y; Rosales MA; Lopes de Faria JB; Lopes de Faria JM
    PLoS One; 2016; 11(2):e0147978. PubMed ID: 26836609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF-1α/VEGF via Activating Nrf2 Antioxidant Pathway.
    Liu C; Cheng T; Wang Y; Li G; Wang Y; Tian W; Feng L; Zhang S; Xu Y; Gao Y; Li J; Liu J; Cui J; Yan J; Cao L; Pan Z; Qi Z; Yang L
    Mol Nutr Food Res; 2024 Feb; 68(4):e2200771. PubMed ID: 38356045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.